Table 1.
Demographics and Treatment Details.a
| Variable | HIV and TB (n = 25) | HIV Alone (n = 25) |
|---|---|---|
| Ageb (years) | 37 (33-40) | 42 (36-48) |
| BMIb (kg/m2) | 17.6 (1.8) | 19.8 (2.4) |
| Male | 18 (72) | 21 (84) |
| Heterosexual mode of transmission | 24 (96) | 23 (92) |
| Site of TB | ||
| Pulmonary | 9 (36) | - |
| Extrapulmonary | 13 (52) | - |
| Disseminated | 3 (12) | - |
| ART duration (in months) | 60 (27-119) | 50 (19-96) |
| ART regimen, n (%) | ||
| D4T + 3TC + NVP | 1 (4) | 9 (36) |
| D4T + 3TC + EFV | 11 (40) | 0 |
| ZDV + 3TC + NVP | 0 | 16 (64) |
| ZDV + 3TC + EFV | 13 (52) | 0 |
| Change in ART regimen | ||
| No change | 7 (28) | 14 (56) |
| Once | 12 (48) | 9 (36) |
| Twice | 6 (24) | 2 (8) |
Abbreviations: ART, antiretroviral therapy; BMI, body mass index; D4T, stavudine; EFV, efavirenz; EPTB, extrapulmonary tuberculosis; NVP, nevirapine; TB, tuberculosis; 3TC, lamivudine; ZDV, zidovudine.
aData are presented as mean (standard deviation); median (interquartile range) or frequency (percentages).
b P value < .05; unpaired t test.